Innovata plc In Anti-Adhesion Drug Deal With Baxter International, Inc.

LONDON, Jan 3 (Reuters) - Innovata Plc said on Tuesday it had agreed a global licensing deal with Baxter International over its treatment for adhesions, or internal scarring, in abdominal, obstetric and gynaecologic surgery.

MORE ON THIS TOPIC